coded
@sneezetrj0
A recent study by Washington University examined 215,000 users of injectable obesity treatments like Ozempic, Wegovy, and Mounjaro and found significant concerns: these users faced twice the risk of pancreatitis, had an 11% higher chance of developing arthritis, and were at increased risk for low blood pressure and serious kidney issues.
0 reply
0 recast
0 reaction